Higher-Than-Recommended Lenalidomide Dosing Is Safe in Transplant-Eligible Newly Diagnosed Multiple Myeloma with Renal Impairment
/ Frida Bugge Askeland / Jan Andreasen
Novel Clinical Data in Mantle Cell Lymphoma Highlighted in ASH 2025 Oral Session
/ Ingrid Cecilia Glimelius
Nordic Study Uncovers a New Minimally Invasive Biomarker for Low-Risk Mantle Cell Lymphoma
/ Ingrid Cecilia Glimelius
Improving CML Outcomes: Nordic CML Study Group Shares New ASH 2025 Insights
/ Henrik Hjorth-Hansen











